SLC2A4 and obesity disorder: By augmenting GLUT4 expression and enhancing glucose uptake, the adverse metabolic effects associated with hyperlipidemia and obesity can be avoided, suggesting that this approach may offer potential therapeutic avenues for managing these conditions (Figure 5).